The drug Tulobuterol functions as a long-acting beta-2 agonist which provides 24-hour respiratory support to patients with breathing problems. The transdermal patch serves as the primary method of drug delivery for Tulobuterol which traditional inhalers and oral tablets do not provide. The drug delivery system enables medication absorption from the skin into the bloodstream at a continuously controlled absorption rate. The device provides treatment for nocturnal asthma through its ability to treat night-time coughing and to enhance respiratory functions in chronic bronchitis and emphysema patients.
How It Works: The “Bronchodilation” Pathway
Beta-2 Stimulation
Tulobuterol creates its effects by binding to specific receptors in the bronchial tubes. The medication interact with these receptors which control muscle movement to create a state where air passages become wider through airway muscle relaxation. The patch technology provides a continuous drug flow which maintains blood drug levels throughout the day and night period because it activates at regular intervals.
The system delivers three main product benefits which include continuous drug delivery for 24 hours and prevention of medication drops that cause breathing problems during nighttime hours. The product offers two main benefits through its design because it maintains sustained airway operation throughout the day while enabling patients to stay without taking extra medications. The system delivers three main product benefits which include continuous drug delivery for 24 hours and prevention of medication drops that cause breathing problems during nighttime hours. The drug maintains therapeutic effects during two separate periods of 12 hours each.
The drug distribution system contains three strength options which include 0.5 mg, 1 mg and 2 mg packages. The system delivers three main product benefits which include continuous drug delivery for 24 hours and prevention of medication drops that cause breathing problems during nighttime hours. The system delivers three main product benefits which include continuous drug delivery for 24 hours and prevention of medication drops that cause breathing problems during nighttime hours. The system delivers three main product benefits which include continuous drug delivery for 24 hours and prevention of medication drops that cause breathing problems during nighttime hours.
The drug Tulobuterol functions as a transdermal patch which doctors prescribe for respiratory treatment of children and elderly patients in India. The Indian market offers Tulobuterol to customers in patch form which doctors use to treat respiratory conditions in both pediatric and elderly patients. The Indian market offers Tulobuterol to customers in patch form which doctors use to treat respiratory conditions in both pediatric and elderly patients. The Indian market offers Tulobuterol to customers in patch form which doctors use to treat respiratory conditions in both pediatric and elderly patients. The Indian market offers Tulobuterol to customers in patch form which doctors use to treat respiratory conditions in both pediatric and elderly patients. The Indian market offers Tulobuterol to customers in patch form which doctors use to treat respiratory conditions in both pediatric and elderly patients. The Indian market offers Tulobuterol to customers in patch form which doctors use to treat respiratory conditions in both pediatric and elderly patients.